CINECA IRIS Institutional Research Information System

ELIA, GIUSY
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.713
AS - Asia 2.384
EU - Europa 2.196
SA - Sud America 545
AF - Africa 144
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.994
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.599
IT - Italia 947
SG - Singapore 742
CN - Cina 682
BR - Brasile 458
HK - Hong Kong 418
SE - Svezia 392
DE - Germania 207
VN - Vietnam 187
BG - Bulgaria 128
GB - Regno Unito 101
RU - Federazione Russa 88
IN - India 69
FR - Francia 66
CA - Canada 65
NL - Olanda 63
FI - Finlandia 59
CI - Costa d'Avorio 51
IQ - Iraq 48
TR - Turchia 48
AR - Argentina 36
MX - Messico 31
BD - Bangladesh 30
JP - Giappone 29
AT - Austria 27
PL - Polonia 26
SN - Senegal 26
ES - Italia 21
NG - Nigeria 21
KR - Corea 20
UA - Ucraina 20
ZA - Sudafrica 18
EC - Ecuador 15
SA - Arabia Saudita 13
CO - Colombia 11
PY - Paraguay 11
ID - Indonesia 10
UZ - Uzbekistan 10
IE - Irlanda 9
PH - Filippine 9
AU - Australia 8
CZ - Repubblica Ceca 8
JO - Giordania 8
PK - Pakistan 8
MA - Marocco 7
CH - Svizzera 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
IL - Israele 5
IR - Iran 5
KE - Kenya 5
TN - Tunisia 5
BY - Bielorussia 4
CR - Costa Rica 4
PS - Palestinian Territory 4
TW - Taiwan 4
UY - Uruguay 4
VE - Venezuela 4
AL - Albania 3
CU - Cuba 3
DO - Repubblica Dominicana 3
MY - Malesia 3
PE - Perù 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BJ - Benin 2
BN - Brunei Darussalam 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
TH - Thailandia 2
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
CY - Cipro 1
EE - Estonia 1
FJ - Figi 1
GA - Gabon 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
QA - Qatar 1
Totale 9.990
Salva come PNG Salva come JPEG
Città #
Ashburn 573
Dallas 525
Fairfield 447
Singapore 422
Hong Kong 412
Santa Clara 385
Woodbridge 264
Chandler 229
Milan 211
Pisa 208
Houston 190
Shanghai 185
Seattle 182
Cambridge 162
Wilmington 147
Serra 145
Sofia 128
Ann Arbor 126
New York 121
Beijing 109
Los Angeles 107
Munich 88
Boardman 84
Princeton 82
Lawrence 55
London 54
Abidjan 51
Medford 49
Rome 47
Florence 46
Redondo Beach 41
Frankfurt am Main 39
Ho Chi Minh City 38
Hefei 36
Ottawa 33
São Paulo 33
Turku 30
Dong Ket 28
Istanbul 28
Buffalo 27
Boulder 26
Dakar 26
Tokyo 25
Des Moines 23
Redwood City 23
San Diego 23
Fuzhou 21
Nanjing 21
Bremen 20
Seoul 20
Warsaw 20
Lagos 19
Hyderabad 18
Sulaymaniyah 18
Dearborn 17
Nuremberg 17
Ogden 16
Rio de Janeiro 16
Livorno 15
Vienna 15
Carrara 14
Helsinki 14
Paris 14
Baghdad 13
Düsseldorf 13
Johannesburg 13
Norwalk 13
Amsterdam 12
Brooklyn 12
Guangzhou 12
Hanoi 12
Phoenix 12
Quanzhou 12
San Jose 12
Chennai 11
Montreal 11
Tianjin 11
Washington 11
Changsha 10
Chicago 10
Tashkent 10
Belo Horizonte 9
Chengdu 9
Council Bluffs 9
Denver 9
Amman 8
Curitiba 8
Dublin 8
Lucca 8
Orem 8
Toronto 8
Wuhan 8
Zhengzhou 8
Brasília 7
Catania 7
Lappeenranta 7
Lauterbourg 7
Mexico City 7
Recife 7
Cascina 6
Totale 6.966
Salva come PNG Salva come JPEG
Nome #
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 229
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 213
Molecular testing in the diagnosis of differentiated thyroid carcinomas 205
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 197
Mechanostructure and composition of highly reproducible decellularized liver matrices 190
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 183
Characterisation of liver matrices 177
Novel therapies for thyroid autoimmune diseases: An update 172
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 171
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 170
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 166
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 164
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 163
New insight in endocrine-related adverse events associated to immune checkpoint blockade 163
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 156
Liver derived decellularised matrices in bioreactors 155
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 154
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 153
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 151
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 150
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 149
Liver decellularised matrices in Quasi-Vivo® bioreactors as in-vitro models of hepatic metabolism 146
Novel treatments for anaplastic thyroid carcinoma 146
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 145
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 145
Recent advances in precision medicine for the treatment of anaplastic thyroid cancer 142
Novel treatment options for anaplastic thyroid cancer 140
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 139
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide 138
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 138
Novel Therapies for Thyroid Autoimmune Diseases 137
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 137
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 136
Immune and inflammatory cells in thyroid cancer microenvironment 136
The protective effect of myo-inositol on human thyrocytes 133
Nutraceuticals in thyroidology: A review of in vitro, and in vivo animal studies 133
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy 131
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 128
Molecular features of aggressive thyroid cancer 125
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 125
Chemokines in thyroid autoimmunity 122
Thyroid Autoimmunity and SARS-CoV-2 Infection 122
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 121
Chemokines in hyperthyroidism 119
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies 119
The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results 116
null 115
The COVID-19, epidemiology, clinic and prevention 114
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 113
Metastases free thyroid cancer patients harbouring TERT mutations may benefit from a more intensive treatment and follow-up 113
Thyroid Metastasis from Primary Breast Cancer 111
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 110
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer 108
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups 107
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases 105
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose 104
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 103
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 102
Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study 99
Antineoplastic effect of doxorubizen in vitro in continuous and primary human anaplastic thyroid cancer cells 98
Precision Medicine in Graves’ Disease and Ophthalmopathy 98
Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer 97
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 97
Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis 96
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 95
Hypothyroidism and metabolic cardiovascular disease 93
Teprotumumab for the treatment of thyroid eye disease 93
Endocrine disruptors and thyroid autoimmunity 93
L-T4 Therapy in Enteric Malabsorptive Disorders 92
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In Vitro 91
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review 90
Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes 90
null 87
High risk of brain tumors in military personnel: a case control study 84
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series 75
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 75
null 73
null 73
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review 72
Myoinositol in Autoimmune Thyroiditis 62
Thyroid autoimmune disorders and cancer 57
Th1 chemokines in autoimmune endocrine disorders 52
Autoimmune Thyroid Diseases and Epigenetics 28
COVID-19 AND CRYOGLOBULINEMIC VASCULITIS. LONG-TERM SURVEY STUDY ON THE IMPACT OF PANDEMIC AND VACCINATION ON A LARGE PATIENT'S POPULATION 19
MIG Th1 chemokine in Vitiligo 5
Interferon-γ-Inducible chemokines in Systemic Lupus Erythematosus 5
Interferon-γ-induced protein 10 in Dengue virus infection 5
Dermatomyositis and chemokines 4
Leishmaniasis and IFN-γ dependent chemokines 4
MIG in psoriatic arthritis 4
Totale 10.361
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.581
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021317 0 0 0 0 0 0 19 60 34 70 25 109
2021/2022809 17 16 31 49 123 103 32 39 70 66 63 200
2022/2023907 137 128 74 53 74 104 38 53 153 6 67 20
2023/2024968 81 93 137 109 138 155 65 23 14 21 39 93
2024/20252.999 142 86 81 169 273 341 273 154 194 338 339 609
2025/20262.394 279 408 587 409 388 315 8 0 0 0 0 0
Totale 10.361